Abstract B039: T-cell–dominated interferon signaling drives immune checkpoint inhibitor–associated pneumonitis and reveals actionable cytokine targets
Paytsar Topchyan(APLA Health), Alexandra Drakaki(APLA Health), Gregory A. Fishbein(University of California, Los Angeles), Willy Hugo(APLA Health), Dimitrios Stefanoudakis(APLA Health), Nikhita Kathuria‐Prakash(University of California, Los Angeles), Leland Damron(APLA Health), Melissa G . Lechner(APLA Health), Richard Watson(APLA Health), Min Zhang(APLA Health), Jarod Olay(APLA Health)
Cited by 0
Related Papers
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
|Current Issues in Molecular Biology|2024|78
Immunotherapy in Cervical and Endometrial Cancer: Current Landscape and Future Directions
|Life|2024|25
VEGF inhibition in urothelial cancer: the past, present and future
|World Journal of Urology|2020|19